RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+41.87%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.39B
AUM Growth
+$1.39B
(+32%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
9.92%
Top 10 Holdings %
Top 10 Hldgs %
75.78%
Holding
46
New
8
Increased
24
Reduced
6
Closed
6
Top Buys
| 1 |
Arrowhead Research
ARWR
|
$73.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
$38.4M |
| 3 |
LivaNova
LIVN
|
$29M |
| 4 |
Qiagen
QGEN
|
$19.1M |
| 5 |
Regenxbio
RGNX
|
$14.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$29.2M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$22.1M |
| 3 |
Edwards Lifesciences
EW
|
$20.3M |
| 4 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$14M |
| 5 |
Bristol-Myers Squibb
BMY
|
$10.7M |
Sector Composition
| 1 | Healthcare | 94.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $289M | 20.88% | 14,969,744 | – | – |
|
|
2
Regenxbio
RGNX
$451M
| $149M | 10.76% | 2,079,555 +201,788 | +11% | +$14.5M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $137M | 9.91% | 4,073,690 -64,270 | -2% | -$2.17M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $129M | 9.33% | 978,551 +290,280 | +42% | +$38.4M |
|
|
5
Arrowhead Research
ARWR
$3.05B
| $113M | 8.14% | 8,299,542 +5,382,981 | +185% | +$73.2M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $61.8M | 4.46% | 5,044,813 +15,351 | +0.3% | +$188K |
|
|
7
Bristol-Myers Squibb
BMY
$96B
| $50M | 3.61% | 903,672 -192,714 | -18% | -$10.7M |
|
|
8
LivaNova
LIVN
$3.08B
| $43M | 3.1% | 431,000 +291,000 | +208% | +$29M |
|
|
LJPC
9
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $39.3M | 2.83% | 1,345,881 +223,341 | +20% | +$6.51M |
|
|
ACHN
10
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $38.3M | 2.76% | 13,541,997 +45,095 | +0.3% | +$128K |
|
11
Arbutus Biopharma
ABUS
$711M
| $37.7M | 2.72% | 5,165,499 +13,884 | +0.3% | +$101K |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $34.7M | 2.5% | 352,200 +105,971 | +43% | +$10.4M |
|
13
Masimo
MASI
$7.59B
| $24.4M | 1.76% | 249,543 +17,543 | +8% | +$1.71M |
|
14
Solid Biosciences
SLDB
$427M
| $22.8M | 1.64% | 675,771 | – | – |
|
15
Vericel Corp
VCEL
$1.83B
| $21.5M | 1.55% | 2,217,916 +150,000 | +7% | +$1.46M |
|
|
AGEN
16
Agenus
AGEN
$133M
| $21.3M | 1.53% | 9,375,451 +61,895 | +0.7% | +$141K |
|
|
17
Qiagen
QGEN
$10.1B
| $19.1M | 1.38% | +529,385 | New | +$19.1M |
|
18
uniQure
QURE
$896M
| $15.5M | 1.12% | 409,370 +2,703 | +0.7% | +$102K |
|
|
CORI
19
DELISTED
Corium International, Inc.
CORI
| $15.4M | 1.11% | 1,923,217 +12,695 | +0.7% | +$102K |
|
20
Illumina
ILMN
$15.8B
| $13.9M | 1% | +49,658 | New | +$13.9M |
|
|
MYOK
21
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $13M | 0.94% | 261,395 +1,725 | +0.7% | +$85.6K |
|
|
VRAY
22
DELISTED
ViewRay, Inc.
VRAY
| $10.2M | 0.74% | 1,474,156 +115,445 | +8% | +$799K |
|
|
PTE
23
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $10M | 0.72% | +426,670 | New | +$10M |
|
24
CareDx
CDNA
$727M
| $9.36M | 0.67% | 764,532 +203,932 | +36% | +$2.5M |
|
25
Apyx Medical
APYX
$75.3M
| $9.06M | 0.65% | 2,082,137 +150,189 | +8% | +$653K |
|